The landscape of accessing prescription medications and associated savings programmes involves specific eligibility criteria and administrative processes. For UK consumers seeking information on prescription medication support, understanding the structure of pharmaceutical savings cards and professional sample programmes is essential. This article examines the details available regarding a specific medication savings card and a professional sample ordering system, based exclusively on the provided source material. It focuses on the operational mechanics, eligibility requirements, and key terms as documented, without extrapolation or external assumptions.
Pharmaceutical Savings Card Programmes
One documented programme offers a savings card for a prescription medication, managed by ConnectiveRx on behalf of AstraZeneca. The programme is designed to provide cost savings for patients with a valid prescription for the medication in question, specifically the capsules and packets formulation. The terms of use outline that the card may be used by eligible commercially insured or covered patients who have no restrictions such as step-edit, prior authorisation, or NDC block on their insurance. For these patients, the card may reduce the out-of-pocket cost to as low as £15 for a 30-day supply, £30 for a 60-day supply, or £30 for a 90-day supply. These costs are subject to a maximum savings limit of $175, $350, and $525 respectively for each supply duration. Patient out-of-pocket expenses may vary, and the patient is responsible for any applicable taxes. The card is non-transferable, limited to one per person, and cannot be combined with any other offer. It is void where prohibited by law, taxed, or restricted.
For patients with an eligible third-party payer, pharmacist instructions indicate that the claim should first be submitted to the primary third-party payer. The balance due is then submitted to Change Healthcare as a secondary payer with a patient responsibility amount and a valid Other Coverage Code of 8. This process may reduce the eligible patient’s out-of-pocket costs to the previously mentioned low amounts, subject to the maximum savings limit for the programme. Reimbursement for the pharmacist is received from Change Healthcare. For cash-paying patients, the claim should be submitted directly to Change Healthcare, which requires a valid Other Coverage Code (e.g., 1). The card will cover up to a maximum of $125 per 30-day supply for these patients, with reimbursement also received from Change Healthcare.
A critical eligibility restriction is stated: individuals enrolled in a state or federally funded prescription insurance programme may not use this savings card, even if they elect to be processed as an uninsured (cash-paying) patient. The offer is explicitly not insurance and is restricted to residents of the United States and Puerto Rico. The total programme benefit amounts are determined unilaterally by AstraZeneca and will not exceed the maximum savings limit. The benefit may be less than the maximum limit depending on the terms of the patient’s plan and may vary among individual patients based on factors determined solely by AstraZeneca. Each patient is responsible for costs above the Patient Total Programme Benefit amounts. AstraZeneca reserves the right to rescind, revoke, or amend the offer, eligibility, and terms of use at any time without notice. The offer is not conditioned on any past, present, or future purchase, including refills, but must be presented along with a valid prescription at the time of purchase.
The programme also includes a delivery service called NEXIUM Direct, which offers free, convenient home delivery of brand-name NEXIUM for patients whose prescription is not covered by insurance or if the price is too high. This service is intended to help provide cost savings. The use of the NEXIUM Savings Card with NEXIUM Direct is suggested to maximise savings. Both the savings card and the delivery service are subject to eligibility, with restrictions applying.
Professional Sample Ordering Programmes
The provided source material also details a sample ordering system intended for licensed healthcare professionals, accessed via a platform such as PfizerPro. This system is not available to the general public. To gain access, a licensed prescriber must enter their professional information within their account. If registration is incomplete, access to sample ordering is not possible. Customer service representatives are available Monday to Friday, 8:00am to 9:00pm Eastern time to assist with account updates or other queries.
Once logged in, sample selections appear based on the user’s eligibility, which is subject to change at any time. Availability of samples is updated periodically. A key feature is that savings cards may be shipped along with product samples, if applicable. The ordering process requires the user to certify that they are a licensed prescriber eligible to request and receive the drug samples in the quantities indicated. The certification confirms that the samples will be used exclusively for the medical treatment of patients in conformity with all relevant state and/or local prescribing and dispensing requirements. The signature serves as confirmation of receipt of the medications if delivered by a company representative, or an intention to acknowledge them upon delivery to the medical office if shipped via common carrier.
For the electronic signature feature, the platform has a specific requirement: to access it, the user must first submit an order via the print, sign, and fax method, and then accept the electronic signature enrolment when prompted. Electronic signature is only available for non-controlled substance samples and savings card requests. The site is intended only for U.S. healthcare professionals, and the information provided is for educational purposes only. The products discussed may have different product labelling in different countries.
Important Considerations for UK Consumers
It is crucial for UK-based consumers to note that the specific programmes and offers detailed in the provided source material are explicitly restricted to residents of the United States and Puerto Rico. The pharmaceutical savings card is not valid in the UK, and the professional sample ordering platform is intended solely for U.S. healthcare professionals. Therefore, the eligibility criteria, savings amounts, delivery services, and sample ordering processes described are not applicable to the UK market.
For UK consumers seeking information on prescription medication costs or access to samples, the relevant programmes would be governed by the National Health Service (NHS) and specific pharmaceutical companies operating within the UK regulatory framework. NHS prescription charges apply in England (with exemptions for certain groups), while prescriptions are free in Scotland, Wales, and Northern Ireland. Some pharmaceutical companies may offer patient support programmes or access schemes for specific medications in the UK, but these would be entirely separate from the U.S.-focused programmes described here.
Conclusion
The provided source material details a U.S.-based pharmaceutical savings card programme for a specific medication, outlining eligibility for commercially insured patients, cost savings structures, and pharmacist instructions for processing claims. It also describes a professional sample ordering system for licensed U.S. healthcare professionals, including access requirements, certification processes, and specific features like electronic signature options. Both programmes are explicitly restricted to the United States and Puerto Rico and are not available to UK consumers. For individuals in the UK, information on prescription medication costs and access must be sought through official NHS channels and UK-specific pharmaceutical company programmes. The operational details and eligibility rules for U.S. programmes do not translate to the UK healthcare system.